The Finnish Funding Agency for Technology and Innovation Report issue

Government
Founded: Helsinki Finland (1983)

Organization Overview

First Clinical Trial
2008
NCT00739713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Tekes - the Finnish Funding Agency for Innovation | The Finnish Funding Agency for Technology and Innovation (TEKES)

Active Ingredients

Drugs in Other Trials (2)

acetium (2 trials)

prulifloxacin (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 2